Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: AJJ who wrote (2956)	3/15/1999 1:07:00 PM
From: Manfred A. Wallner	Read Replies (1) \| Respond to of 3702

TO GOLFDAD... I'M POSTING HERE because I don't seem to be smart enough to post on YAHOO!. Two questions: 1) what does VTA do to the neovasculature of wound healing, or for example the collateral circulation after something like a superficial femoral thrombosis (or a coronary artery thrombosis)? 2) I assume the reason that TNT is injected directly into glioblastomas is because of the blood-brain barrier. For visceral tumors I assume that parenteral administration would be sufficient, and that TNT would seek out its target like a "majic bullet". Is this correct?